PubMed

HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed.

Zolopa AR, Shafer RW, Warford A, Montoya JG, Hsu P, Katzenstein D, Merigan TC, Efron B.

Ann Intern Med. 1999 Dec 7;131(11):813-21.PMID: 10610625 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy.

Piketty C, Race E, Castiel P, Belec L, Peytavin G, Si-Mohamed A, Gonzalez-Canali G, Weiss L, Clavel F, Kazatchkine MD.

AIDS. 1999 Jul 30;13(11):F71-7.PMID: 10449277 [PubMed - indexed for MEDLINE]Related articles

Ritonavir and saquinavir combination therapy for the treatment of HIV infection.

Cameron DW, Japour AJ, Xu Y, Hsu A, Mellors J, Farthing C, Cohen C, Poretz D, Markowitz M, Follansbee S, Angel JB, McMahon D, Ho D, Devanarayan V, Rode R, Salgo M, Kempf DJ, Granneman R, Leonard JM, Sun E.

AIDS. 1999 Feb 4;13(2):213-24.PMID: 10202827 [PubMed - indexed for MEDLINE]Related articles

Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure.

Deeks SG, Grant RM, Beatty GW, Horton C, Detmer J, Eastman S.

AIDS. 1998 Jul 9;12(10):F97-102.PMID: 9677159 [PubMed - indexed for MEDLINE]Related articles

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy.

Deeks SG, Hecht FM, Swanson M, Elbeik T, Loftus R, Cohen PT, Grant RM.

AIDS. 1999 Apr 16;13(6):F35-43.PMID: 10397555 [PubMed - indexed for MEDLINE]Related articles

High-dose saquinavir plus ritonavir: long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic response.

Paredes R, Puig T, Arnó A, Negredo E, Balagué M, Bonjoch A, Jou A, Tuldrà A, Tural C, Sirera G, Veny A, Romeu J, Ruiz L, Clotet B.

J Acquir Immune Defic Syndr. 1999 Oct 1;22(2):132-8.PMID: 10843526 [PubMed - indexed for MEDLINE]Related articles

Baseline HIV drug resistance profile predicts response to ritonavir-saquinavir protease inhibitor therapy in a community setting.

Harrigan PR, Hertogs K, Verbiest W, Pauwels R, Larder B, Kemp S, Bloor S, Yip B, Hogg R, Alexander C, Montaner JS.

AIDS. 1999 Oct 1;13(14):1863-71.PMID: 10513644 [PubMed - indexed for MEDLINE]Related articles

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Cvetkovic RS, Goa KL.

Drugs. 2003;63(8):769-802. Review.PMID: 12662125 [PubMed - indexed for MEDLINE]Related articles

Clinical cross-resistance between the HIV-1 protease inhibitors saquinavir and indinavir and correlations with genotypic mutations.

Schapiro JM, Winters MA, Lawrence J, Merigan TC.

AIDS. 1999 Feb 25;13(3):359-65.PMID: 10199226 [PubMed - indexed for MEDLINE]Related articles

Virologic responses to a ritonavir--saquinavir-containing regimen in patients who had previously failed nelfinavir.

Tebas P, Patick AK, Kane EM, Klebert MK, Simpson JH, Erice A, Powderly WG, Henry K.

AIDS. 1999 Feb 4;13(2):F23-8.PMID: 10202820 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics and resistance mutations affect virologic response to ritonavir/saquinavir-containing regimens.

Pellegrin I, Breilh D, Birac V, Deneyrolles M, Mercié P, Trylesinski A, Neau D, Saux MC, Fleury HJ, Pellegrin JL.

Ther Drug Monit. 2001 Aug;23(4):332-40.PMID: 11477313 [PubMed - indexed for MEDLINE]Related articles

The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy.

Staszewski S, Babacan E, Stephan C, Haberl A, Carlebach A, Gute P, Klauke S, Hermschulte Y, Stuermer M, Dauer B; Frankfurt HIV Cohort.

J Antimicrob Chemother. 2006 Nov;58(5):1024-30. Epub 2006 Sep 6.PMID: 16956902 [PubMed - indexed for MEDLINE]Related articlesFree article

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.PMID: 11813503 [PubMed - indexed for MEDLINE]Related articles

Salvage therapy with regimens containing ritonavir and saquinavir in extensively pretreated HIV-infected patients.

Fätkenheuer G, Hoetelmans RM, Hunn N, Schwenk A, Franzen C, Reiser M, Jütte A, Rockstroh J, Diehl V, Salzberger B.

AIDS. 1999 Aug 20;13(12):1485-9.PMID: 10465071 [PubMed - indexed for MEDLINE]Related articles

Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study.

Lorenzi P, Opravil M, Hirschel B, Chave JP, Furrer HJ, Sax H, Perneger TV, Perrin L, Kaiser L, Yerly S.

AIDS. 1999 Feb 4;13(2):F17-21.PMID: 10202819 [PubMed - indexed for MEDLINE]Related articles

Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients.

Casado JL, Perez-Elías MJ, Antela A, Sabido R, Martí-Belda P, Dronda F, Blazquez J, Quereda C.

AIDS. 1998 Jul 30;12(11):F131-5.PMID: 9708403 [PubMed - indexed for MEDLINE]Related articles

Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia.

Deeks SG, Barbour JD, Grant RM, Martin JN.

AIDS. 2002 Jan 25;16(2):201-7.PMID: 11807304 [PubMed - indexed for MEDLINE]Related articles

Predictive factors for response to a boosted dual HIV-protease inhibitor therapy with saquinavir and lopinavir in extensively pre-treated patients.

von Hentig N, Babacan E, Staszewski S, Stürmer M, Doerr HW, Lötsch J.

Antivir Ther. 2007;12(8):1237-46.PMID: 18240863 [PubMed - indexed for MEDLINE]Related articles

Efficacy of salvage therapy containing ritonavir and saquinavir after failure of single protease inhibitor-containing regimens.

Hall CS, Raines CP, Barnett SH, Moore RD, Gallant JE.

AIDS. 1999 Jul 9;13(10):1207-12.PMID: 10416524 [PubMed - indexed for MEDLINE]Related articles

Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor.

Grabar S, Pradier C, Le Corfec E, Lancar R, Allavena C, Bentata M, Berlureau P, Dupont C, Fabbro-Peray P, Poizot-Martin I, Costagliola D.

AIDS. 2000 Jan 28;14(2):141-9.PMID: 10708284 [PubMed - indexed for MEDLINE]Related articles